This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revisionNext revision | Previous revision | ||
| bacteria:t3e:xopt [2024/08/06 14:14] – [XopT] rkoebnik | bacteria:t3e:xopt [2025/07/04 23:46] (current) – jfpothier | ||
|---|---|---|---|
| Line 1: | Line 1: | ||
| - | ====== The Type III Effector XopT from Xanthomonas ====== | + | ====== The Type III Effector XopT from //Xanthomonas// ====== |
| Author: [[https:// | Author: [[https:// | ||
| - | Internal reviewer:\\ | ||
| - | Expert reviewer: **WANTED!** | ||
| Class: XopT\\ | Class: XopT\\ | ||
| Line 20: | Line 18: | ||
| TT3S-dependent translocation of XopT has been shown by a calmodulin-dependent adenylate cyclase reporter assay (Furutani //et al//., 2009). | TT3S-dependent translocation of XopT has been shown by a calmodulin-dependent adenylate cyclase reporter assay (Furutani //et al//., 2009). | ||
| + | |||
| === Regulation === | === Regulation === | ||
| Line 39: | Line 38: | ||
| Furutani A, Takaoka M, Sanada H, Noguchi Y, Oku T, Tsuno K, Ochiai H, Tsuge S (2009). Identification of novel type III secretion effectors in // | Furutani A, Takaoka M, Sanada H, Noguchi Y, Oku T, Tsuno K, Ochiai H, Tsuge S (2009). Identification of novel type III secretion effectors in // | ||
| + | |||
| + | ===== Acknowledgements ===== | ||
| + | |||
| + | This fact sheet is based upon work from COST Action CA16107 EuroXanth, supported by COST (European Cooperation in Science and Technology). | ||